Lars Erik Gustafsson

Title: Lars Erik Gustafsson: Innovator in Therapeutic Compounds

Introduction

Lars Erik Gustafsson is a notable inventor based in Hasselby, Sweden. He has made significant contributions to the field of therapeutic compounds, holding a total of seven patents. His work focuses on innovative methods for delivering gaseous nitric oxide and producing organic nitrites for pharmaceutical applications.

Latest Patents

Gustafsson's latest patents include compositions and methods for delivering gaseous nitric oxide (NO) to mammals for prophylactic or therapeutic purposes. This involves a composition capable of forming a reversible bond or association with NO. Additionally, he has developed methods for manufacturing therapeutic compounds and compositions. These methods utilize organic nitrites produced from mono/polyhydric alcohols or aldehyde- or ketone-derivatives after de-aeration, using NO gas. The resulting organic nitrites exhibit fewer impurities and improved storage stability compared to conventionally produced nitrites, making them suitable for various medical treatments.

Career Highlights

Throughout his career, Gustafsson has worked with several companies, including Aerocrine AB. His innovative approaches have led to advancements in the pharmaceutical industry, particularly in the development of stable and effective therapeutic compounds.

Collaborations

Gustafsson has collaborated with notable individuals in his field, including Dag Linnarsson and Kristofer Nilsson. These partnerships have contributed to the success of his projects and the advancement of therapeutic technologies.

Conclusion

Lars Erik Gustafsson is a prominent inventor whose work in therapeutic compounds has the potential to impact medical treatments significantly. His innovative patents and collaborations highlight his dedication to advancing pharmaceutical science.